Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What impact does tigecycline's patent extension have on alternative drug prices?Is liver enzyme increase common in prolonged tigecycline treatment?Does alcohol consumption have any positive cognitive impacts?What's the typical timeframe for lipitor to curb cravings?How does vascepa affect salt intake?
See the DrugPatentWatch profile for lyrica
How does Lyrica impact fibromyalgia-related fatigue? Lyrica (pregabalin) has been prescribed off-label to treat fibromyalgia, a condition characterized by widespread pain, fatigue, and tenderness. Research suggests that Lyrica may help alleviate fatigue associated with fibromyalgia [1]. Studies have shown that Lyrica can reduce fatigue symptoms in fibromyalgia patients. A 2010 trial published in the Journal of Pain and Symptom Management found that patients taking Lyrica experienced significant improvements in fatigue, pain, and sleep quality compared to placebo [2]. Another study published in 2013 in the Journal of Pain Research found that Lyrica reduced fatigue in fibromyalgia patients, with 43% of participants experiencing clinically significant reductions in fatigue [3]. The exact mechanisms by which Lyrica reduces fatigue are not fully understood, but it is thought to involve its effects on pain perception and sleep [4]. By reducing pain and improving sleep, Lyrica may help alleviate fatigue associated with fibromyalgia. What side effects should patients be aware of? While Lyrica may help reduce fatigue, patients should be aware of potential side effects, including dizziness, drowsiness, and weight gain [5]. It is essential for patients to discuss the benefits and risks of Lyrica with their healthcare provider before starting treatment. Can other treatments be used in combination with Lyrica? Combining Lyrica with other treatments, such as antidepressants, pain medications, or lifestyle modifications, may enhance its effectiveness in reducing fatigue [6]. Patients should consult with their healthcare provider to develop a comprehensive treatment plan tailored to their specific needs. Patent and exclusivity Lyrica's patent expired in 2018, allowing generic versions to enter the market [7]. This may lead to increased accessibility and affordability for patients. Sources: [1] http://www.drugpatentwatch.com/patent/US20020116041 [2] http://www.ncbi.nlm.nih.gov/pubmed/20889231 [3] http://www.ncbi.nlm.nih.gov/pubmed/23843423 [4] http://www.drugpatentwatch.com [5] http://www.drugs.com/side-effects/lyrica.html [6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397617/ [7] http://www.drugpatentwatch.com/patent/US20020116041
Other Questions About Lyrica :